Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases

NCT06757426 is registered in ClinicalTrials.gov with Groupe français d'étude des Maladies Inflammatoires de loeil as lead sponsor.

NCT NCT06757426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06757426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases
Lead sponsor
Groupe français d'étude des Maladies Inflammatoires de loeil
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2025
Completion date
July 15, 2028
Enrollment
80 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, inflammatory diseases